Home » Stocks » PROG

Progenity, Inc. (PROG)

Stock Price: $3.27 USD -0.02 (-0.61%)
Updated December 3, 4:00 PM EST - Market closed
After-hours: $3.29 +0.03 (0.77%) Dec 3, 7:59 PM

Stock Price Chart

Key Info

Market Cap 153.38M
Revenue (ttm) 80.51M
Net Income (ttm) -167.48M
Shares Out 46.63M
EPS (ttm) -3.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $3.27
Previous Close $3.29
Change ($) -0.02
Change (%) -0.61%
Day's Open 3.18
Day's Range 3.08 - 3.31
Day's Volume 2,940,608
52-Week Range 3.08 - 13.12

More Stats

Market Cap 153.38M
Enterprise Value 166.63M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 46.63M
Float n/a
EPS (basic) n/a
EPS (diluted) -3.59
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 183,604
Short Ratio 1.94
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.91
PB Ratio n/a
Revenue 80.51M
Operating Income n/a
Net Income -167.48M
Free Cash Flow n/a
Net Cash -13.26M
Net Cash / Share -0.28
Gross Margin 54.02%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -111.71%
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 2
Overweight 2
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(259.88% upside)
Current: $3.27
Target: 11.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth12.51%-
Gross Profit43.4935.90
Operating Income-140-114
Net Income-148-129
Shares Outstanding4.884.66
Earnings Per Share-46.87-27.72
Operating Cash Flow-106-65.13
Capital Expenditures-3.73-4.83
Free Cash Flow-110-69.96
Cash & Equivalents33.0469.21
Total Debt73.3772.74
Net Cash / Debt-40.33-3.53
Book Value-83.87-36.97
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Progenity, Inc.
Country United States
Employees 702
CEO Harry Stylli

Stock Information

Ticker Symbol PROG
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: PROG
IPO Date June 19, 2020


Progenity, a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.